As of 30 Sep 2025, 0 institutional investors reported holding $0 in principal (par value) of STANDARD BIOTOOLS INC - NOTE 2.750% 2/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $0 | $0 | -$7,956 | 0 | |
| 2025 Q2 | $42,008 | $49,505 | -$31,595 | 49774.46% | 2 |
| 2025 Q1 | $74,008 | $80,965 | -$790,843 | 98.74% | 6 |
| 2024 Q4 | $82,008 | $864,014 | +$790,840 | 98.9% | 7 |
| 2024 Q3 | $74,008 | $81,134 | -$37,646 | 98.97% | 6 |
| 2024 Q2 | $112,008 | $118,874 | +$20,828 | 99.07% | 8 |
| 2024 Q1 | $91,008 | $97,958 | -$6,140 | 98.94% | 5 |
| 2023 Q4 | $97,008 | $104,285 | +$38 | 99.37% | 6 |
| 2023 Q3 | $97,008 | $102,243 | +$27,908 | 97.8% | 6 |
| 2023 Q2 | $68,008 | $73,204 | -$723,177 | 96.32% | 4 |
| 2023 Q1 | $35,008 | $796,048 | +$697,839 | 95.35% | 5 |
| 2022 Q4 | $97,008 | $656,532 | -$2,820 | 93.99% | 6 |
| 2022 Q3 | $99,008 | $100,000 | 95.0% | 5 | |
| 2022 Q2 | $99,008 | $102,000 | 95.24% | 5 | |
| 2022 Q1 | $99,008 | $102,000 | 95.24% | 5 | |
| 2021 Q4 | $99,008 | $104,000 | 97.62% | 5 | |
| 2021 Q3 | $57,008 | $64,000 | 100.0% | 4 | |
| 2021 Q2 | $57,008 | $64,000 | +$6,000 | 100.0% | 4 |
| 2021 Q1 | $51,008 | $57,000 | -$111,774 | 96.77% | 3 |
| 2020 Q4 | $169,008 | $171,000 | +$8,459 | 100.0% | 4 |
| 2020 Q3 | $160,008 | $169,000 | +$4,071 | 100.0% | 5 |
| 2020 Q2 | $155,674 | $157,000 | -$28,076 | 100.0% | 6 |
| 2020 Q1 | $184,342 | $183,000 | +$14,781 | 95.42% | 6 |
| 2019 Q4 | $187,008 | $185,000 | -$48,231,706 | 95.83% | 7 |
| 2019 Q3 | $49,853,008 | $48,419,000 | +$926,186 | 96.6% | 9 |
| 2019 Q2 | $48,953,008 | $47,041,000 | +$101,247 | 95.82% | 12 |
| 2019 Q1 | $48,886,008 | $46,140,000 | +$130,460 | 94.47% | 11 |
| 2018 Q4 | $48,737,000 | $44,919,000 | +$686,685 | 92.49% | 13 |
| 2018 Q3 | $48,652,000 | $42,465,000 | +$179,208 | 86.96% | 15 |
| 2018 Q2 | $48,529,000 | $39,223,000 | +$1,989,286 | 80.99% | 15 |
| 2018 Q1 | $44,849,000 | $38,813,000 | -$127,003,331 | 84.8% | 17 |
| 2017 Q4 | $195,639,000 | $162,372,000 | +$9,014,579 | 83.06% | 22 |
| 2017 Q3 | $176,305,000 | $129,892,000 | -$2,658,682 | 73.85% | 22 |
| 2017 Q2 | $184,175,000 | $115,125,000 | +$673,377 | 62.02% | 27 |
| 2017 Q1 | $181,692,000 | $123,358,000 | +$186,602 | 67.9% | 27 |
| 2016 Q4 | $181,203,000 | $126,727,000 | -$5,281,806 | 70.0% | 31 |
| 2016 Q3 | $180,459,122 | $117,566,000 | -$1,356,718,436 | 61.07% | 34 |
| 2016 Q2 | $186,918,011 | $112,683,007 | +$7,740,211 | 60.0% | 32 |
| 2016 Q1 | $185,179,006 | $102,011,499 | -$225,512 | 55.0% | 33 |
| 2015 Q4 | $185,714,006 | $116,245,475 | -$7,017,805 | 61.89% | 35 |
| 2015 Q3 | $195,192,000 | $141,427,000 | +$7,956,667 | 72.99% | 31 |
| 2015 Q2 | $196,405,000 | $173,661,000 | -$21,013,168 | 87.96% | 29 |
| 2015 Q1 | $197,896,000 | $209,580,000 | +$28,779,759 | 106.2% | 30 |
| 2014 Q4 | $165,461,483 | $152,255,614 | -$26,021,960 | 90.4% | 36 |
| 2014 Q3 | $187,486,170 | $166,647,937 | +$5,421,794 | 89.07% | 36 |
| 2014 Q2 | $176,814,170 | $167,499,999 | +$14,939,125 | 94.81% | 33 |
| 2014 Q1 | $163,408,000 | $186,181,000 | +$177,640,000 | 113.95% | 23 |